Cisplatin

C-X-C motif chemokine receptor 4 ; Homo sapiens







21 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35391718 Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. 2022 1
2 34023505 A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer. 2021 Oct 6 2
3 34916377 CXCR4 and RIF1 overexpression induces resistance of epithelial ovarian cancer to cisplatin-based chemotherapy. 2021 Oct-Dec 3
4 32390763 TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma. 2020 3
5 30554431 CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma. 2019 Feb 4
6 29436676 Vandetanib inhibits cisplatin‑resistant neuroblastoma tumor growth and invasion. 2018 Apr 2
7 27922681 CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner. 2017 Feb 6
8 28196146 Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer. 2017 1
9 28446538 Chitosan nanoparticle-delivered siRNA reduces CXCR4 expression and sensitizes breast cancer cells to cisplatin. 2017 Jun 30 1
10 28498420 CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo. 2017 Jun 1
11 28721072 CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells. 2017 1
12 26819076 Low-dose cisplatin-induced CXCR4 expression promotes proliferation of ovarian cancer stem-like cells. 2016 Mar 1
13 29797935 [Investigation of CXCR4 mediated chemoresistance in nasopharyngeal carcinoma cell line CNE2]. 2016 Jun 5 8
14 25544759 Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. 2015 Jan 20 6
15 26020117 Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer. 2015 May 28 1
16 26020124 Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer. 2015 Jul 1
17 26141860 Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis. 2015 Sep 1 2
18 24209634 Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer. 2014 Jan 5
19 24408020 Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells. 2014 May 7
20 19671192 Vesnarinone downregulates CXCR4 expression via upregulation of KrĂĽppel-like factor 2 in oral cancer cells. 2009 Aug 12 1
21 16331601 Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. 2006 May 1 2